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Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurode-
generative disorder characterized by progressive loss of
motor neurons. However, ALS has been recognized to
also involve non-motor systems. Subclinical involve-
ment of the autonomic system in ALS has been de-
scribed. The recently developed 13C-octanoic acid breath
test allows the noninvasive measurement of gastric
emptying. With this new technique we investigated 18
patients with ALS and 14 healthy volunteers. None of the
patients had diabetes mellitus or other disorders known
to cause autonomic dysfunction. The participants re-
ceived a solid standard test meal labeled with 13C-octa-
noic acid. Breath samples were taken at 15-min intervals
for 5 h and were analyzed for 13CO2 by isotope selective
nondispersive infrared spectrometry. Gastric emptying
peak time (tpeak) and emptying half time (t½) were deter-
mined. All healthy volunteers displayed normal gastric
emptying with a mean emptying t½ of 138 B 34 (range
68–172) min. Gastric emptying was delayed (t½ 1 160
min) in 15 of 18 patients with ALS. Emptying t½ in ALS
patients was 218 B 48 (range 126–278) min (p ! 0.001).
These results are compatible with autonomic involve-
ment in patients with ALS, causing delayed gastric
emptying of solids and encouraging the theory that ALS
is a multisystem disease rather than a disease of the
motor neurons only.
Introduction
Amyotrophic lateral sclerosis (ALS) is the progressive
degeneration of corticobulbar, corticospinal, brainstem
and spinal cord motor neurons. Clinical manifestations
comprise muscle weakness, muscle atrophy, hyperreflex-
ia, spasticity and bulbar paresis. The disease rarely devel-
ops before the third decade and occurs sporadically in
most instances. Familial occurrence with an autosomal
dominant trait is observed in about 10% of cases. The sen-
sory apparatus, the regulatory mechanisms for control
and coordination of movement, as well as the intellect and
thinking remain intact. There is consistent selectivity in
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Table 1. Baseline characteristics of control group, ALS patients and subgroups
Control group
(n = 14)
ALS total
(n = 18)
Site of onset
bulbar
(n = 9)
limb
(n = 9)
Bulbar involvement
none or mild
(n = 6)
moderate or severe
(n = 12)
8/6 11/7 6/3 5/4 3/3 7/4
Age, years 59.2B12.6 62.6B8.7 63.5B4.8 61.2B12.0 62.3B4.6 62.7B10.4
Disease duration, months – 22.4B12.5 19.1B7.8 26.8B15.7 21.3B14.6 29.6B15.1
Norris score – 66.4B12.7 68.9B5.8 63.2B17.4 55.4B16.1 72.5B11.4
motor system involvement. The motor neurons required
for ocular motility remain unaffected as do the parasym-
pathetic neurons in the sacral spinal cord which innervate
the sphincters of the bowel [1].
However, subclinical or clinical involvement of neu-
ronal areas other than motor neurons has been described.
Lowe [2], e.g., reported on characteristic pathological
findings in the non-motor cortex and in many subcortical
structures in long-term survivors. End-stage ALS patients
may also present non-motor clinical symptoms such as
emotional changes like involuntary laughing and crying or
frontal lobe dementia. In the last years new techniques
in measuring autonomic function showed involvement
of autonomic cardial and sudomotor regulation in ALS
[3–5].
Radioactive isotope methods are currently considered
the gold standard for measurement of gastric emptying.
The 13CO2 isotope breath test has been developed as a
nonradioactive alternative [6]. A test meal is labeled with
the stable, nonradioactive isotope 13C. The principle of
this test is based on the oxidation of the labeled short-
chain fatty acid to 13CO2 after emptying the labeled acid
together with the test meal from the stomach. The 13CO2/
12CO2 ratio is analyzed by isotope selective nondispersive
infrared spectrometry from exhaled air.
The aim of the present study was to investigate gastric
emptying times in order to assess gastrointestinal auto-
nomic function in patients with ALS.
Subjects and Methods
The baseline characteristics of the healthy volunteers and the
ALS patients and subgroups are given in table 1. 18 patients (7 wom-
en and 11 men; mean age 62.6 B 8.7, range 38–74 years) participated
in the study. The diagnosis of ALS was based on conventional clinical
criteria [1]. Patients with further neurological diseases or systemic
diseases known to cause autonomic dysfunction like diabetes melli-
tus were excluded. None of the patients had gastrointestinal diseases
or gastrointestinal surgery. No case of familial ALS was included in
the study. 14 healthy, age-matched volunteers served as a control
group (mean age 59.2 B 12.6, range 32–68 years). None of the
patients or volunteers took antibiotics or any medication known to
influence intestinal transit times. The study protocol was approved
by the Ethics Committee of the University of Munich and written
informed consent was obtained from all patients.
According to the site of disease onset 2 groups of patients were
differentiated. Bulbar-onset disease was defined as initial symptoms
in the bulbar region, and limb-onset disease as initial symtoms in the
limbs, even if there was bulbar involvement at the time of enrollment
[7]. Further, patients were divided into subgroups depending on the
degree of bulbar involvement at the time of measurement. According
to a bulbar involvement score [8] 2 groups were differentiated, 1 with
no or mild bulbar impairment (score 0–7), and the other with moder-
ate to marked impairment (score 8–15). The disease duration (in
months), the total score of the Norris scale [9], and upper motor neu-
ron involvement [8] were correlated with gastric emptying half time
(t½) and peak time (tpeak).
Test Meal and 13C-Octanoic Acid Breath Test Technique
In both groups, patients and controls, gastric emptying tests were
performed in the sitting position at 9 a.m. after an overnight fast. The
patients received a solid standard test meal consisting of 1 scrambled
egg, labeled with 100 mg 13C-octanoic acid, 12 g rye breat, 15 g but-
ter, 20 g jam, 25 g cheese spread and 200 ml tea (caloric content 586
kcal, 12% protein, 42% fat, 46% carbohydrates). Octanoic acid has
been used as a tracer molecule because it is poorly absorbed in the
stomach, but rapidly absorbed and metabolized in the duodenum
[10]. Breath samples were taken baseline and thereafter at 15-min
intervals for 5 h and were analyzed for 13CO2 by isotope selective
nondispersive infrared spectrometry (Wagner Analysentechnik,
Worpswede, Germany). Using a nonlinear regression method, gastric
emptying t½ were determined. In addition, the time of maximum
13CO2 excretion (peak of the gastric emptying curve, tpeak) has been
determined. The mathematical model used to analyze the results is
described in full detail by Ghoos et al. [6]. The parameters were com-
puted as suggested by Ghoos et al. [6]: emptying t½ = (1/k) W
ln(1 – 2–(1/ß)) – 66, and tpeak = (1/k) W ln(b) – 66.
Statistical Analysis
Data are given as mean B 1 SE. The results of the groups and
subgroups were analyzed and compared by the Mann-Whitney
U test, simple linear regression and correlation. p values of ! 0.05
were considered significant.
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Fig. 1. 13CO2 enrichment in breath (mean B
SD) over time (min) after receiving the test
meal in healthy volunteers and in ALS pa-
tients. DOB = Delta over base.
Fig. 2. Gastric emptying half time (t½) and
peak time (tpeak) in healthy controls (n = 14)
and in ALS patients (n = 18).
Results
All participants consumed their test meal within a
maximum of 16 min (range, patients 8–16 min; control
group 6–12 min). In healthy volunteers 13CO2 excretion
resulted in a rapid peak with a peak maximum (tpeak) at 87
B 23 (range 48–128) min, followed by an exponential
decay (fig. 1, 2). Curve fitting of the averaged data by non-
linear regression led to a mean t½ of 138 B 34 min in this
group (range 68–172 min; fig. 1, 2). In ALS patients, the
13CO2 excretion tpeak was 186 B 39 (range 85–236) min
(p ! 0.001 compared to controls) and gastric emptying t½
was 218 B 41 (range 126–272) min (p ! 0.001 compared
to controls; fig. 1, 2). The gastric emptying times, t½ and
1
2
t½, min
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Table 2. Gastric emptying half time (t½) and peak time (tpeak) of ALS patients, subgroups and control group
Control group
(n = 14)
ALS total
(n = 18)
Site of onset
bulbar
(n = 9)
limb
(n = 6)
Bulbar involvement
none or mild
(n = 6)
moderate or severe
(n = 12)
138B34 218B41 226B29 212B33 208B34 232B40
tpeak, min 87B23 186B39 193B35 176B24 183B28 188B39
h f
p ! 0.001
h f
n.s.
h f
n.s.
tpeak, were not significantly correlated with bulbar in-
volvement or upper motor neuron involvement. The
mean duration of the disease was 22.4 B 12.5 (range 6–
48) months. Gastric emptying times did not correlate with
the duration of the disease. The ALS group showed a
mean Norris score of 66.4 B 12.7 (range 85–39) without
correlation to the gastric emptying times. There was also
no correlation between gastric emptying delay and upper
motor neuron involvement. Eight patients described
symptoms compatible with gastroparesis (fullness after
food intake or nausea). However, a correlation with
delayed gastric emptying times could not be demon-
strated. In the ALS subgroup with moderate or marked
bulbar symptoms, t½ was more delayed compared to the
subgroup with no or just mild bulbar symptoms, although
subgroup analysis did not reveal statistical significance
(table 2). Differentiating ALS patients into 2 subgroups,
1 with bulbar onset disease and 1 with limb onset disease,
showed that t½ and tpeak were more delayed in the group
with bulbar onset, but did not result in significant differ-
ences (table 2).
Discussion
In the last years subclinical or clinical involvement of
non-motor areas in ALS has repeatedly been described.
New techniques in measuring autonomic function re-
vealed evidence of autonomic involvement, i.e. cardial
and sudomotor regulation, in ALS. Performing autore-
gressive spectral analysis of heart rate variability, Pisano
et al. [3] and Chida et al. [11] demonstrated a vagal-sym-
pathetic imbalance in patients with ALS. These cardial
alterations were not related to clinical features or to the
duration of the disease. Prolonged sympathetic skin re-
sponse latencies in patients with ALS were reported by
Dettmers et al. [12] with absent sympathetic skin re-
sponses in one or both legs in 40% of ALS patients. Provi-
cialli et al. [5] evaluated skin abnormalities in patients
with skin biopsies and suggested autonomic involvement
in ALS during the early stages of the disease.
Gastric emptying patterns have not yet been assessed
in ALS. The 13C-octanoic acid breath test is a valid and
well-reproducible method to measure gastric emptying
[13–15]. It has been shown that gastric emptying mea-
sured by breath tests correlated well with scintigraphic
studies [6, 13, 16]. Breath sample collection for the 13CO2
breath test does not inconvenience patients and can be
performed even in patients with advanced disease. The
patient does not need to stay in the same position for sev-
eral hours as is required for scintigraphic measurements.
Only a small amount of air from the last phase of exhaling
blown into a special bag is necessary for data aquisition.
After careful instructions, most patients were able to col-
lect the breath samples themselves on the appropriate
time schedule. Only patients with advanced paresis in the
upper limbs needed help. Because 13CO2 measurements
do not need to be done immediately, the breath samples
can be mailed to an analytical laboratory.
Gastric emptying is a complex process governed by
multiple factors. The consistence and the caloric density
of the meal are as important as the neural regulation and
motor activity of the stomach. Solid and liquid phases of a
meal are emptied in different patterns from the stomach.
In pathological conditions, such as autonomic gastropare-
sis, gastric emptying of solids is delayed first [17, 18].
However, the majority of patients with gastric transit dis-
orders have delayed emptying of both liquids and solid
food [13]. Measuring gastric emptying of solids is more
sensitive for the detection of delayed gastric transit than
measuring the emptying of liquids. Furthermore, repro-
ducibility is better using solid test meals than liquids
[19].
Diabetic patients with autonomic gastroparesis often
do not complain of gastrointestinal symptoms. Due to the
lack of specific complaints autonomic gastrointestinal dis-
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turbances in diabetes mellitus are certainly underesti-
mated [20, 21]. We have evaluated gastrointestinal symp-
toms in the ALS patients, but there was no correlation
with delayed gastric emptying. However, gastrointestinal
complaints reported by ALS patients, like constipation,
diffuse abdominal pain and a feeling of fullness, may fur-
ther support the theory of gastrointestinal autonomic
involvement in ALS.
All patients could chew and swallow the test meal with-
in normal time limits (16 min). Thus, esophageal transit
did not seem to affect gastric emptying. None of the
patients or volunteers took medication known to in-
fluence intestinal transit. 10 patients were treated with
riluzole (50 mg twice daily). Riluzole, an inhibitor of glu-
tamate release, is the first drug to be approved in the
United States for the treatment of ALS. These patients
had no side effects from this medication. However, 6
patients who were not treated with riluzole exhibited
markedly delayed gastric empyting as well.
In summary, the noninvasive 13C octanoic acid breath
test is a feasible diagnostic tool to assess delayed gastric
emptying in patients with ALS. Whether delayed gastric
emptying in patients with ALS has to be interpreted as
autonomic involvement in the context of a subclinical
non-motor involvement remains to be elucidated by fur-
ther studies involving a larger number of patients. Con-
sidering ALS as a multisystem disease rather than simply
a disease of motor neurons may have major implications
for research into pathogenesis. Delayed gastric emptying
in ALS patients might be of clinical relevance since symp-
toms related to disturbed gastrointestinal transit may fur-
ther reduce food intake and may be improved in part by
prokinetic drugs. This technique may also be helpful to
assess therapeutic estimates and the course of the dis-
ease.
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